Correction: Preclinical Development of 1B7/CD3, a Novel Anti-tslpr Bispecific Antibody That Targets CRLF2-Rearranged Ph-Like B-all

Authors

Ze Tian
Chunhua Shi
Guojun Yang
Jason K Allen
Qing Shi
Amin Al-Shami
Jill Wardell Olson
Melinda G Smith
Qing Chang
Jasbir Kaur
Junping You
Timothy E Lofton
Michelle A Gonzalez
Qi Zhang
DongXing Zha
Sarah K Tasian
Nitin Jain
Marina Y Konopleva
Timothy Heffernan
Jeffrey J Molldrem

Language

English

Publication Date

1-1-2024

Journal

Leukemia

DOI

10.1038/s41375-023-02090-w

PMID

38036631

PMCID

PMC10776386

PubMedCentral® Posted Date

11-30-2023

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Tian, Ze; Shi, Chunhua; Yang, Guojun; et al., "Correction: Preclinical Development of 1B7/CD3, a Novel Anti-tslpr Bispecific Antibody That Targets CRLF2-Rearranged Ph-Like B-all" (2024). Faculty, Staff and Student Publications. 6295.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6295